Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Caprius(CAPR), Breast MRI(former ANMR/MAMO) -- Ignore unavailable to you. Want to Upgrade?

To: luis a. garcia who wrote (2524)	5/29/1998 7:33:00 PM
From: Sandra	Read Replies (2) \| Respond to of 2615

Luis, The last news release sent off some powerful signals as far as fundamentals go too, especially this part: Sandra Jack Nelson, Caprius' Chairman & CEO, stated: ''The broad recognition by the health care insurers, including Medicare, of the value of the Aurora for breast imaging is an endorsement of the fundamental underpinning of our Company; namely, that MRI of the breast can yield beneficial results for many women and is cost effective.'' Caprius, Inc. is dedicated to the development and commercialization of the Aurora system, a breast imaging system based on magnetic resonance imaging (MRI). The Aurora is the only FDA-cleared, MRI-based dedicated breast imaging system in the United States.